Provepharm is advancing surgical precision with plans to launch two innovative dyes in 2026, supporting minimally invasive ...

Hepatocellular carcinoma (HCC) is a major global health issue, with significant morbidity and mortality rates. As the sixth most common cancer and the third leading cause of cancer-related deaths, HCC ...

As many as 40% of lumpectomies leave positive margins that necessitate a second surgery, but a novel fluorescent imaging agent used along with a direct visualization system may improve complete ...

INSITE Trial included more than 400 patients at 14 leading academic and community cancer centers Intracavity visualization system uses fluorescence imaging designed to identify residual cancer and ...

Successful surgery for head and neck squamous cell carcinoma (HNSCC) relies upon complete tumor removal and safe preservation of the fragile nerves in the vicinity. Both are challenging. Fluorescence ...

A research group from Nagoya University has successfully developed a surgical training model using konjac, a processed jelly made from the bulb of the konjac plant. Konjac is commonly used as an ...

Light-guided cancer surgery has been in development for some time with varying degrees of success, from light therapy to glow-in-the-dark tumors and the development of compounds that can illuminate ...

Getinge AB is acquiring 100% of the equity in fluorescence imaging company Fluoptics SAS, a company using the technology as an aid to surgery. Getinge will, through its subsidiary Getinge Infection ...

ADELAIDE, Australia, Dec. 17, 2025 /PRNewswire/ -- Australian company Ferronova has raised a further $6 million to progress the commercialisation of a novel nanoparticle image-guided surgery solution ...

In a significant leap forward for successful cancer surgery, researchers at the University of Missouri and collaborators have developed a new imaging probe to help surgeons more accurately identify ...